"We're seeing a surprising number of patients who were vaccinated and are still affected by the virus," he said. "We think the vaccine is not a perfect match with strains that are coming through the area."
Alger said she noticed improvement after the first dose on the new drug.
"Last night after my first dosing, my cough had improved, as well as the irritation in my chest," she said.
After three doses, Derek Peterson dramatically recovered. He was really sick. In fact, initially, he could hardly make it to north Foothill Clinic for his first treatment.
"I mean, I curled up in a ball in a fetal position, just miserable," he said. "I was like that the entire first day."
It appears to work against a variety of influenzas, including bird flu and the so-called para-influenza bugs. Since the compound is a derivative from natural human flora, the mist produces no allergic reactions.
If the third-stage clinical trials prove out, the FDA could approve the compound within the year under its "fast-track" program. The Utah study group is looking for more volunteers to test the new drug. For more information go to www.jlewisresearch.com or call 801-480-9392.
Contributing: Jennifer Stagg and Carole Mikita
- British judge hears arguments in case LDS...
- Utah prosecutors forward allegations against...
- LDS missionary from Utah dies in Micronesia
- Parties have now finalized arguments in...
- Why Syracuse mom killed her 2 daughters still...
- Looking for the perfect Pi Day pie? Here are...
- BYU chemist makes breakthrough discovery on...
- Kaysville man with MS shares hope with others
- Utah recognition of same-sex marriage... 72
- British judge hears arguments in case... 42
- LDS missionary from Utah dies in... 41
- Parties have now finalized arguments in... 41
- Cyclists killed in early morning crash... 35
- Utah prosecutors forward allegations... 34
- House report: John Swallow hung 'for... 32
- BYU chemist makes breakthrough... 29